Clinical trial
Salvage Radiation Therapy and Taxotere for PSA Failure After Radical…
NCT00480857 · University of Michigan Rogel Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00480857 |
|---|---|
| Title | Salvage Radiation Therapy and Taxotere for PSA Failure After Radical Prostatectomy |
| Official title | Salvage Radiation Therapy and Docetaxel (Taxotere) for Biochemical Failure After Radical Prostatectomy |
| Lead sponsor | University of Michigan Rogel Cancer Center, Other |
| Collaborators | Sanofi Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | Docetaxel (Taxotere) |
| Enrollment | 19 |
| Start date | Mar 1, 2007 |
| Primary completion | Aug 1, 2013 |
| Completion | Jul 1, 2014 |
| First posted | May 31, 2007 |
| Last update posted | Oct 6, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: